title: Dose-dependent transitions in mechanisms of toxicity.
abstract: Scientists and decision makers from all sectors agree that risk assessments should be based on the best available science. Several years ago, the Health and Environmental Sciences Institute (HESI), a global branch of the International Life Sciences Institute (ILSI), identified the need for better scientific understanding of dose-dependent transitions in mechanisms of toxicity as one avenue by which the best and latest science can be integrated into the decision making process. In July 2001, the HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity established a group of academic, government, and industry scientists to engage in active technical discourse on the issue of dose-dependent transitions in mechanisms of toxicity. Over the next 18 months, case studies were examined. These case studies included acetaminophen, butadiene, ethylene glycol, formaldehyde, manganese, methylene chloride, the peroxisome proliferator-activated receptor, progesterone/hydroxyflutamide, propylene oxide, vinyl acetate, vinyl chloride, vinylidene chloride, and zinc (Slikker, W., Jr., Andersen, M.E., Bogdanffy, M.S., Bus, J.S., Cohen, S.D., Conolly, R.B., David, R.M., Doerrer, N.G., Dorman, D.C., Gaylor, D.W., Hattis, D., Rogers, J.M., Setzer, R.W., Swenberg, J.A., Wallace, K., 2004. Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol. Appl. Pharmacol. 201(3), 226-294 (this issue)). The HESI Project Committee sponsored two technical workshops in 2003. The first of these workshops took place on February 12-13, 2003, and was co-sponsored by the Agency for Toxic Substances and Disease Registry, the American Chemistry Council, the National Institute of Environmental Health Sciences, the Society of Toxicology, and the U.S. Environmental Protection Agency. Additional support was provided by Health Canada. Invited experts from government, academia, and industry provided scientific perspectives and recommendations at the workshop. The purpose of the workshop was to examine approaches to dose-response analysis, learn from the case study examples, and gather feedback from invited participants on the impact of dose-dependent transitions on the risk assessment process. The second forum consisted of a workshop in March 2003 at the Society of Toxicology Annual Meeting in Salt Lake City, UT. This paper addresses the issues discussed at both workshops, and presents the consensus conclusions drawn by expert participants.
authors.affiliation: US FDA National Center for Toxicological Research, Jefferson, AR 72079, USA.
authors.forename: William
authors.initials: W
authors.lastname: Slikker
authors.forename: Melvin E
authors.initials: ME
authors.lastname: Andersen
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Bogdanffy
authors.forename: James S
authors.initials: JS
authors.lastname: Bus
authors.forename: Steven D
authors.initials: SD
authors.lastname: Cohen
authors.forename: Rory B
authors.initials: RB
authors.lastname: Conolly
authors.forename: Raymond M
authors.initials: RM
authors.lastname: David
authors.forename: Nancy G
authors.initials: NG
authors.lastname: Doerrer
authors.forename: David C
authors.initials: DC
authors.lastname: Dorman
authors.forename: David W
authors.initials: DW
authors.lastname: Gaylor
authors.forename: Dale
authors.initials: D
authors.lastname: Hattis
authors.forename: John M
authors.initials: JM
authors.lastname: Rogers
authors.forename: R Woodrow
authors.initials: RW
authors.lastname: Setzer
authors.forename: James A
authors.initials: JA
authors.lastname: Swenberg
authors.forename: Kendall
authors.initials: K
authors.lastname: Wallace
mesh_terms: D000818:Animals; D018736:DNA Adducts / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008658:Inactivation, Metabolic; D012107:Research Design; D018570:Risk Assessment
chemical_list: D018736:DNA Adducts